Operating Income (Loss) in USD of Biofrontera Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biofrontera Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2020 to Q3 2025.
  • Biofrontera Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$6.28M, a 26.6% decline year-over-year.
  • Biofrontera Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$17.6M, a 9.03% increase year-over-year.
  • Biofrontera Inc. annual Operating Income (Loss) for 2024 was -$17.2M, a 24.1% increase from 2023.
  • Biofrontera Inc. annual Operating Income (Loss) for 2023 was -$22.7M, a 22% decline from 2022.
  • Biofrontera Inc. annual Operating Income (Loss) for 2022 was -$18.6M, a 26.3% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Biofrontera Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$17.6M -$6.28M -$1.32M -26.6% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 -$16.3M -$5.08M -$8K -0.16% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 -$16.3M -$4.55M +$920K +16.8% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$17.2M -$1.71M +$2.15M +55.7% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$19.4M -$4.96M -$340K -7.36% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 -$19M -$5.07M +$3.63M +41.7% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$22.7M -$5.47M +$25K +0.46% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$22.7M -$3.87M +$1.75M +31.2% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025
Q3 2023 -$24.4M -$4.62M -$981K -27% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$23.5M -$8.7M -$2.49M -40% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$21M -$5.49M -$2.38M -76.6% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$18.6M -$5.62M -$3.74M -199% 01 Oct 2022 31 Dec 2022 10-K 15 Mar 2024
Q3 2022 -$14.8M -$3.64M +$12.5M +77.4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$27.3M -$6.21M -$2.53M -68.5% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$24.8M -$3.11M +$418K +11.8% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 -$25.2M -$1.88M 01 Oct 2021 31 Dec 2021 8-K 03 Oct 2023
Q3 2021 -$16.1M -$13.8M -587% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$3.69M 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 -$3.53M 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q3 2020 -$2.34M 01 Jul 2020 30 Sep 2020 10-Q 30 Nov 2021

Biofrontera Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.2M +$5.47M +24.1% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$22.7M -$4.1M -22% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
2022 -$18.6M +$6.62M +26.3% 01 Jan 2022 31 Dec 2022 10-K 15 Mar 2024
2021 -$25.2M -$15.6M -162% 01 Jan 2021 31 Dec 2021 8-K 03 Oct 2023
2020 -$9.61M 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.